Remibrutinib Impurities
Remibrutinib is a highly selective, covalent Bruton’s tyrosine kinase (BTK) inhibitor under investigation for autoimmune diseases such as multiple sclerosis, chronic spontaneous urticaria, and other inflammatory disorders. Its impurity profile includes structurally related analogs, residual solvents, and degradation products formed under stress conditions such as hydrolysis, oxidation, and photolysis. Furthermore, typical degradation pathways involve oxidative modification of the heteroaromatic scaffold, hydrolytic cleavage of amide bonds, and rearrangement of substituents within the carbamoyl framework. These impurities may affect the drug’s potency, stability, and safety. Importantly, all impurities are structurally characterized and qualified according to ICH guidelines for toxicological assessment and analytical validation.
Remibrutinib EP Impurities
Pharmacopeial and non-pharmacopeial Remibrutinib impurity compounds are available in compliance with European Pharmacopoeia (EP) specifications. These standards support analytical method development, impurity profiling, and long-term stability studies. In addition, EP traceable materials are supplied with validated analytical data, including purity, structural confirmation, and spectral characterization.
Remibrutinib Related Compounds
Structurally related compounds and synthetic analogs associated with Remibrutinib are included for impurity identification, toxicological qualification, and regulatory submission. Consequently, these related substances are used in forced degradation studies, genotoxicity assessments, and impurity threshold evaluations. They are essential for understanding the impurity profile and ensuring compliance with regulatory limits.
Remibrutinib Impurity Reference Standards
Remibrutinib impurity reference standards are provided with validated analytical data, including purity, NMR, MS, and full Certificates of Analysis. These standards are used in pharmaceutical research, method validation, and GMP-compliant quality control. Additionally, EP/USP traceable entries are available upon request and are routinely re-tested to ensure consistency and reliability.
